Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $1.79 Million - $9.65 Million
460,400 Added 80.87%
1,029,700 $13 Million
Q1 2024

May 15, 2024

SELL
$3.76 - $6.02 $3.39 Million - $5.43 Million
-902,300 Reduced 61.31%
569,300 $2.72 Million
Q4 2023

Feb 14, 2024

SELL
$4.8 - $7.67 $2.44 Million - $3.89 Million
-507,800 Reduced 25.65%
1,471,600 $7.06 Million
Q3 2023

Nov 14, 2023

BUY
$6.81 - $9.74 $2.56 Million - $3.66 Million
375,600 Added 23.42%
1,979,400 $14.3 Million
Q2 2023

Aug 14, 2023

BUY
$6.67 - $9.52 $10.7 Million - $15.3 Million
1,603,800 New
1,603,800 $11.9 Million
Q3 2022

Nov 14, 2022

BUY
$18.2 - $76.12 $7.21 Million - $30.2 Million
396,100 New
396,100 $7.21 Million
Q4 2021

Feb 14, 2022

BUY
$134.56 - $217.97 $207 Million - $335 Million
1,534,700 New
1,534,700 $220 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.